CXCR4 and Decreased total neutrophil count: These observations suggest that the efficacy of CXCR4 antagonists in mobilizing neutrophils and correcting peripheral blood neutropenia may be compound-specific and influenced by several factors such as pharmacokinetic properties, tissue distribution, residence time on CXCR4 receptor, and the duration of antagonist treatment.